ArticleVaccines2022

Effectiveness of Booster Dose of Anti SARS-CoV-2 BNT162b2 in Cirrhosis: Longitudinal Evaluation of Humoral and Cellular Response.

Vincenzo Giambra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.